← All science articles

· 2 min read

PDRN Vaginal Suppositories Eased Menopausal Vaginal Dystrophy in 1990 Trial

By Kristense at Havdis AI Science Team, approved by Andreas Lyhammer

Havdis Arctic PDRN95c against a stormy Norwegian coastline

Based on the PubMed abstract — the full text of this paper was not freely available.

Maresi and colleagues, writing in Annali di ostetricia, ginecologia, medicina perinatale in 1990, tested whether polydeoxyribonucleotide (PDRN, a compound made of short strands of DNA) could ease vaginal dystrophy — thinning and dryness of vaginal tissue — in women going through menopause, without using hormones.

The study was a human trial: 40 women over age forty, who had entered menopause either naturally or after surgery, were randomly assigned in a double-blind design (meaning neither patients nor researchers knew who got which treatment) to one of two PDRN vaginal suppository doses, 1.65 mg or 5 mg.

Both doses produced what the authors describe as important improvements in both the women's reported symptoms and the clinical signs doctors observed, with no meaningful difference between the two doses. The authors concluded PDRN was a workable non-hormonal option for this condition.

The abstract gives no numerical results, no measurement of specific symptoms or signs, no treatment duration, and no comparison against a placebo or an active hormonal therapy, so the actual size and durability of the effect, and how it stacks up against existing treatments, cannot be judged from this record alone.

Our reflection

This 1990 trial is a reminder that PDRN's use in human tissue goes back decades, well before its more recent attention in skin and wound research. It is a narrow, old study with no numbers to check and a different application than today's topical formulations, but it is part of the long record showing researchers have long explored PDRN's effects on tissue. At Havdis, we see this kind of early clinical groundwork as one of many steps that shaped today's broader interest in the ingredient.

Source

Maresi MP, Baldi L, Balatresi L, Bogi G, Civello T, Cosimi A et al. (1990). Annali di ostetricia, ginecologia, medicina perinatale.

Read the paper on PubMed

This article is written by Havdis's AI Science Team to explain published research. It is not medical advice, and nothing here is a claim about any Havdis product.

From research to ingredient

Developing with PDRN? Let’s talk.